UBS Group
NBTX

UBS Group’s Nanobiotix NBTX Stock Holding History

UBS Group’s Portfolio NBTX Stock Details NBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97.2K Sell
2,577
-2,980
-54% -$111K ﹤0.01% 7206
2026
Q1 		$172K Buy
5,557
+4,027
+263% +$106K ﹤0.01% 6719
2025
Q4 		$35.4K Sell
1,530
-631
-29% -$13.8K ﹤0.01% 7420
2025
Q3 		$40.8K Sell
2,161
-2,257
-51% -$19.2K ﹤0.01% 7705
2025
Q2 		$20.9K Buy
4,418
+1,418
+47% +$5.49K ﹤0.01% 8399
2025
Q1 		$10.7K Sell
3,000
-817
-21% -$2.82K ﹤0.01% 8601
2024
Q4 		$11K Buy
3,817
+717
+23% +$2.87K ﹤0.01% 8268
2024
Q3 		$17.8K Hold
3,100
– – ﹤0.01% 7436
2024
Q2 		$15.5K Hold
3,100
– – ﹤0.01% 7468
2024
Q1 		$20.1K Hold
3,100
– – ﹤0.01% 6927
2023
Q4 		$22.6K Sell
3,100
-706
-19% -$4.47K ﹤0.01% 7035
2023
Q3 		$33.3K Sell
3,806
-196
-5% -$1.63K ﹤0.01% 6537
2023
Q2 		$20.3K Buy
4,002
+1,002
+33% +$4.55K ﹤0.01% 6861
2023
Q1 		$10.6K Sell
3,000
-798
-21% -$3.07K ﹤0.01% 7567
2022
Q4 		$13.9K Buy
3,798
+755
+25% +$2.91K ﹤0.01% 8117
2022
Q3 		$11K Buy
3,043
+2
+0.1% +$8 ﹤0.01% 8311
2022
Q2 		$11K Sell
3,041
-778
-20% -$4.18K ﹤0.01% 7826
2022
Q1 		$26K Sell
3,819
-2,194
-36% -$17.4K ﹤0.01% 7150
2021
Q4 		$48K Sell
6,013
-54,340
-90% -$532K ﹤0.01% 6938
2021
Q3 		$686K Buy
60,353
+562
+0.9% +$7.51K ﹤0.01% 4502
2021
Q2 		$824K Sell
59,791
-10,391
-15% -$163K ﹤0.01% 4345
2021
Q1 		$1.05M Buy
70,182
+69,836
+20,184% +$1.2M ﹤0.01% 4191
2020
Q4 		$6K Buy
+346
New +$5.96K ﹤0.01% 7765

Other funds holding NBTX

JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SHIM
Stone House Investment Management Tunkhannock, Pennsylvania $752M AUM 20.1% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

UBS Group's NBTX Position: Q2 2026 in Review

UBS Group reduced its Nanobiotix (NBTX) stake by 54% in Q2 2026, selling an estimated $111K and leaving 2,577 shares worth $97.2K. The position accounts for ﹤0.01% of the portfolio, ranked #7206.

UBS Group first reported a position in NBTX in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.05M in Q1 2021. 11 funds tracked by Wall St. Rank hold NBTX as of Q2 2026.

  • UBS Group held 2,577 shares of Nanobiotix worth $97.2K as of Q2 2026.
  • UBS Group sold 2,980 Nanobiotix shares in Q2 2026, an estimated $111K.
  • Nanobiotix made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7206 holding.
  • UBS Group first reported a position in Nanobiotix in Q4 2020 and has held it in 23 quarters since.
  • UBS Group's Nanobiotix position peaked at $1.05M in Q1 2021.
  • 11 funds tracked by Wall St. Rank held Nanobiotix as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.